LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
Keyword(s):
Keyword(s):
Keyword(s):
2013 ◽
Vol 15
(8)
◽
pp. 770-773
◽
2020 ◽
2019 ◽
Vol 43
(5)
◽
pp. 653-662